Published in New England Journal of Medicine · View the paper (DOI)
The combination of baricitinib and remdesivir reduced median time to recovery in hospitalized COVID-19 patients from eight days to seven days. Patients who required high-flow oxygen or non-invasive ventilation during their hospitalization showed the largest benefit, with a significant improvement in condition at day 15.
Coverage from 2 institutions